导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 15.00% | 238/1050 |
| 近一周 | -2.73% | 706/1104 |
| 近一月 | -6.60% | 776/1102 |
| 近一季 | -7.27% | 542/1092 |
| 近半年 | 17.20% | 172/1070 |
| 近一年 | 15.26% | 286/1018 |
| 近两年 | 150.59% | 101/926 |
| 近三年 | 66.20% | 170/834 |
| 成立以来 | 195.84% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-9.99% 1001/1070 |
82.93% 93/1101 |
- - |
- - |
| 2025 | 29.15% 486/1065 |
12.18% 96/1014 |
2.40% 475/1038 |
28.73% 377/1050 |
-12.66% 948/1065 |
| 2024 | 8.04% 330/1011 |
-20.57% 946/960 |
-2.58% 469/983 |
9.00% 711/991 |
28.09% 5/1011 |
| 2023 | -9.77% 323/952 |
4.18% 364/880 |
-10.09% 774/895 |
-9.76% 580/915 |
6.75% 13/952 |
| 2022 | -27.45% 566/867 |
-20.98% 574/773 |
11.36% 211/806 |
-14.87% 555/845 |
-3.15% 585/867 |
| 2021 | 45.88% 19/740 |
-7.81% 443/580 |
32.48% 45/659 |
16.42% 27/704 |
2.61% 326/740 |
| 2020 | 62.02% 184/554 |
11.62% 37/419 |
23.28% 222/466 |
6.82% 325/517 |
10.22% 353/554 |
| 2019 | - - |
- - |
-8.67% 943/1228 |
21.96% 13/390 |
18.09% 24/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 信澳先进智造股票型 VS. 东吴新产业精选股票A(580008) |